Ignite Creation Date:
2025-12-26 @ 2:39 PM
Ignite Modification Date:
2026-02-25 @ 11:04 PM
Study NCT ID:
NCT03107806
Status:
TERMINATED
Last Update Posted:
2019-08-15
First Post:
2013-04-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Monitoring Glucose Levels in Patients With Myocardial Infarction
Sponsor:
Lars Ryden
Organization:
Study Overview
Official Title:
COMGAMI Continuous Monitoring of Glucose in Acute Myocardial Infarction
Status:
TERMINATED
Status Verified Date:
2017-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Blood withdrawal problems despite use of different catheters.
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
COMGAMI
Brief Summary:
To evaluate the OptiScanner® for continuous glucose monitoring as a tool to optimize glucose levels in patients hospitalized for acute coronary syndromes
Detailed Description:
Methodology Part a) Explorative Part b) Randomised, parallel-group design
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: